Press releases

. . .

		AboutBoard of directors
Management
Who we are
We build...CompaniesOverview
Internal Portfolio
Companies we’ve helped build
Accelerator
EcosystemsOverview
Innovation Centres
adMare Community
TalentOverview
Executive Institute
BIS Program
Experiential  Learning
adMare Institute
News
Events
CareersCulture
Open positions
Press Room
Contact us
Newsletter

			Terms and conditions
    
Français

adMare

Press releases
vertical
																																	
adMare BioInnovations Spins Out Analytical Services to Paraza Pharma, Catalyzing Growth and InnovationadMare news

								Read
							
Epitopea Closes USD $31 million Pre-Series A FinancingadMare newsPortfolio companies

								Read
							
Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome TreatmentadMare news

								Read
							
adMare BioInnovations Appoints Marc Rivière to its Board of DirectorsadMare news

								Read
							
NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare DiseasesadMare newsResident companies

								Read
							
Find Therapeutics Announces the Closing of a Convertible Note Financing with Investissement QuébecadMare newsPortfolio companies

								Read
							
Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine CarcinomaadMare news

								Read
							
PharmaEssentia Announces Licensing Agreement with FORUS Therapeutics to Commercialize BESREMi® (ropeginterferon alfa-2b-njft) in CanadaadMare news

								Read
							
SOFIAC Canada enables decarbonization of adMare BioInnovations' buildings with a $3.275M investmentadMare news

								Read
							
adMare BioInnovations Opens Applications for the Fall Cohorts of the BioInnovation Scientist ProgramsadMare AcademyadMare news

								Read
							
adMare BioInnovations Expands with New Wet Laboratory Space in VancouveradMare news

								Read
							
adMare Academy Opens Applications for Cohort VII of its Executive InstituteAccelerator companiesadMare news

								Read
							
adMare BioInnovations Welcomes Five New Start-Ups in the National Tx AcceleratorAccelerator companiesadMare news

								Read
							
adMare BioInnovations Opens Applications for the Spring 2024 Cohort of the BioInnovation Scientist Program: Foundations and Launches New Biopharma Industry Essentials Program adMare AcademyadMare news

								Read
							
adMare Institute Announces Speaker Series to Explore Ecosystems, Clusters and Anchor Companies in Canadian Life Sciences IndustryadMare news

								Read
							
Happy Holidays from the adMare BioInnovations TeamadMare news

								Read
							
adMare BioInnovations Welcomes 22 Influential Life Sciences Leaders to Cohort VI of the adMare Academy Executive InstituteadMare AcademyadMare news

								Read
							
The adMare Institute Examines the Critical Role of Anchor Companies in Building Globally Competitive Life Sciences Innovation EcosystemsadMare news

								Read
							
adMare BioInnovations Launches the Refreshed Version of the adMare Community with New Engaging FeaturesadMare news

								Read
							
adMare BioInnovations and MaRS Discovery District Welcome Inaugural Ontario Start-Ups to Therapeutics Accelerator ProgramAccelerator companiesadMare news

								Read
							
adMare BioInnovations Appoints John DeLucchi, Martin LeBlanc, and Tim van Biesen to the Board of DirectorsadMare news

								Read
							
adMare BioInnovations invites early-career science professionals to apply to the BioInnovation Scientist (BIS) Program: Foundations Cohort IIadMare AcademyadMare news

								Read
							
Landmark Report Published on the Status of Inclusion, Diversity, Equity and Accessibility (IDEA) in Canada’s Life Sciences SectoradMare insightsadMare news

								Read
							
CPDC Funds Research at Simon Fraser University for Developing an LAT1-targeting Pet Tracer for Imaging CanceradMare news

								Read
							
Applications Now Open for Cohort VI of the adMare Academy Executive Institute ProgramadMare AcademyadMare news

								Read
							
adMare BioInnovations Launches the adMare InstituteadMare news

								Read
							
adMare BioInnovations Achieved Prestigious LEED Green Building CertificationadMare news

								Read
							
New strategy positions B.C. as a global hub for life sciencesadMare news

								Read
							
adMare BioInnovations launches the BioInnovation Scientist (BIS) Program: Foundations and invites early-career science professionals to apply to be part of the inaugural cohortadMare AcademyadMare news

								Read
							
MaRS partners with adMare BioInnovations to develop Therapeutics AcceleratorAccelerator companiesadMare news

								Read
							
adMare Bioinnovations and PRiME Next-Generation Precision Medicine Collaborate to Translate Academic Research into Life Changing TherapeuticsadMare news

								Read
							
adMare BioInnovations Launches the adMare Tx Accelerator to Support Growth of Promising Early-stage Therapeutics Ventures across CanadaAccelerator companiesadMare news

								Read
							
adMare Appoints Travis McCready to the Board of DirectorsadMare news

								Read
							
adMare BioInnovations and Medicine by Design Partner to Support Translation Priorities in the Toronto Life Sciences EcosystemadMare news

								Read
							
Immugenia Obtains Pre-Seed Funding from adMare BioInnovations, ACET Capital, and Sherbrooke Innopole to Develop a Cancer Treatment Which Would Prevent RelapsesadMare newsPortfolio companies

								Read
							
adMare BioInnovations Announces a Strong Cohort for Its Academy’s Executive Institute 2022-2023 ProgramadMare AcademyadMare news

								Read
							
New partnership between Genome Canada and adMare BioInnovations to drive commercialization of genomics solutions in healthcareadMare news

								Read
							
Canadian Biotech Industry Recognizes Top PerformersadMare news

								Read
							
adMare Appoints Patricia Gauthier to the Board of DirectorsadMare news

								Read
							
Anie Perrault joins adMare as Vice President, Public Affairs and CommunicationsadMare news

								Read
							
adMare Appoints Dr. Christine Allen as Vice-President, Ecosystem DevelopmentadMare news

								Read
							
adMare BioInnovations joins a $42m Series A financing in Domain TherapeuticsadMare newsPortfolio companies

								Read
							
adMare BioInnovations Collaborates with Accelerator Company, Molecular Forecaster Inc. on Computational Approaches to Drug DiscoveryAccelerator companiesadMare news

								Read
							
Government of Canada Invests $92 million in adMare to help translate health research into innovative new therapies in CanadaadMare news

								Read
							
adMare supports Ukraine; Responds to Ministers Champagne and DuclosadMare news

								Read
							
Specific Biologics Closes Seed Financing with Industry Leaders Lumira Ventures and adMare BioInnovationsadMare newsPortfolio companies

								Read
							
adMare BioInnovations Announces Successful Applicants to 2021-2022 Executive InstituteadMare AcademyadMare news

								Read
							
adMare BioInnovations and uOttawa Work Together to Translate University Research into Strong New Canadian Life Science CompaniesadMare news

								Read
							
adMare BioInnovations and CASTL Partner to Build Canada’s Biomanufacturing TalentadMare AcademyadMare news

								Read
							
adMare BioInnovations and District 3 Innovation partner to provide science-based Canadian startups more cohesive support to grow into industry leadersadMare news

								Read
							
adMare’s President & CEO Gordon C. McCauley is Appointed to BIOVECTRA Board of DirectorsadMare news

								Read
							
adMare and AazeinTx Inc Sign Global Exclusive AgreementadMare news

								Read
							
adMare BioInnovations launches Canada’s first & only digital life sciences communityadMare news

								Read
							
New Canadian Pharmaceutical Company Brings Novel Cancer Therapies To MarketadMare newsPortfolio companies

								Read
							
adMare Launches Abdera with AbCellera as a Founding PartneradMare newsPortfolio companies

								Read
							
Join us in the 50 – 30 ChallengeadMare news

								Read
							
adMare BioInnovations Welcomes the First Quebec Start-Ups in its Accelerate ProgramAccelerator companiesadMare news

								Read
							
Developing Canada’s Next Generation of Commercial Life ScientistsadMare AcademyadMare news

								Read
							
Didier Leconte Elected Chair of adMare BoardadMare news

								Read
							
Unleashing Canada’s Radiopharmaceutical ExcellenceadMare news

								Read
							
Global Pandemic Drives Unprecedented Need to Grow Canada’s Life Science LeadershipadMare AcademyadMare news

								Read
							
adMare is pleased to increase our investment in Inversago Pharma alongside leading life sciences investors and be a part of building this exceptional Canadian company developing innovative therapiesadMare newsPortfolio companies

								Read
							
CDL Health and adMare BioInnovations partner to accelerate the commercialization of health innovationsadMare news

								Read
							
adMare BioInnovations Launches a New Acceleration Program for Quebec Emerging CompaniesAccelerator companiesadMare news

								Read
							
adMare BioInnovations Strengthens Leadership TeamadMare news

								Read
							
Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in MontrealadMare newsPortfolio companies

								Read
							
New Company to Advance Research into Made-in-Canada Therapy for Patients with Chronic PainadMare newsPortfolio companies

								Read
							
adMare Academy Executive Institute – Developing Canada’s Life Sciences Leaders in a COVID World and BeyondadMare AcademyadMare news

								Read
							
On the Cutting-Edge of the Fight Against the PandemicadMare news

								Read
							
adMare and BELLUS Health Close Transaction for Intellectual Property Rights to P2X3 PlatformadMare newsPortfolio companies

								Read
							
adMare BioInnovations & Accel-Rx Unite to Advance the Canadian Life Sciences SectoradMare news

								Read
							
adMare BioInnovations Appoints Dr. Mounia Azzi as Vice President, Program Development and PartnershipsadMare news

								Read
							
adMare Academy Announces New Executive Institute Cohort to Drive the Canadian Life Sciences Industry ForwardadMare AcademyadMare news

								Read
							
Life Sciences & Health Technology Innovation Hub Takes Shape in MontrealadMare news

								Read
							
adMare BioInnovations Appoints Dr. Youssef Bennani as Venture PartneradMare news

								Read
							
CDRD & NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovationsadMare news

								Read
							
Newsletter

Stay up to date on the

latest adMare news
Subscribe
Français
Vancouver Innovation Centre2405 Wesbrook Mall

Vancouver, British Columbia, Canada

V6T 1Z3
T. 604.827.1147
Toronto OfficeMaRS Centre, West Tower

661 University Ave., Suite 405

Toronto, Ontario, Canada

M5G 1M1
T. 416.673.8100
Montreal Innovation Centre7171 Frederick-Banting

Montréal, Québec, Canada

H4S 1Z9
T. 514.375.3334
We

	build ...
Companies
Ecosystems
Talent
Who we are
adMare Institute
News
Events
Careers
Newsletter
Contact Us
Press Room
  
adMare

Community
Français
adMare BioInnovations Année all rights reserved - Privacy policy
Website by Riposte
 
                    Powered by